Compare Kraft Heinz Co (KHC) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kraft Heinz Co vs Novo Nordisk A/S — how do they compare? Kraft Heinz Co trades at $24.68 (market cap $29.23B), while Novo Nordisk A/S trades at $45.9 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 7.1× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (6.49%). Which is the better fit depends on your goals.
| KHC | NVO | |
|---|---|---|
Market Cap | $29.23B | $207.85B |
Sector | Consumer Staples | Health |
52-Week High | $28.06 | $63.98 |
52-Week Low | $21.21 | $35.29 |
Enterprise Value | $45.55B | $222.55B |
Dividend Yield | 6.49% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
